PubMed Health⌕ Search

Biomedical subjects

H A Wilson

Publications and source records attributed to H A Wilson.

26 records · Page 2Linked to original sources

Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Sera from 20 patients with systemic lupus erythematosus (SLE) and active central nervous system (CNS) dysfunction were examined by indirect immunofluorescence for antibodies to neuronal membrane determinants. Warm-reactive IgG antibodies were demonstrable in 82% (9/11) of patients with clinical evidence for seizures or diffuse CNS disease, but these antibodies generally were absent in non-CNS SLE sera or when focal neurologic deficit or psychosis was the primary CNS manifestation. Cold-reactive antibodies of the IgM class were equally prevalent in patients with or without CNS disease and appeared to be more directly correlated with extra-CNS systemic illness. Absorption experiments with lymphocytes, brain homogenate, and various other tissues suggested a predominant brain-specificity for IgG antibodies and partial lymphocyte cross-reactivity for IgM antibodies. Interpretations of this special association between IgG anti-brain antibodies and diffuse CNS dysfunction in SLE are discussed.

Autoantibodies↗

Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine.

1. Twenty-one haloalkylamine derivatives were tested as inhibitors of both the neuronal uptake of (3)H-noradrenaline (NA) by the Uptake(1) mechanism and the extraneuronal uptake of (3)H-NA by the Uptake(2) mechanism in the isolated rat heart.2. At a concentration of 50 muM most of the compounds tested caused a significant inhibition of both uptake processes, although there were wide differences in the relative effects on Uptake(1) and Uptake(2). Some tentative structure activity relationships for uptake inhibition were formulated from these results.3. Phenoxybenzamine was confirmed to be a potent inhibitor of both the Uptake(2) and Uptake(1) mechanisms, with IC50 values for these two systems of 2.8 muM and 0.9 muM respectively.4. The substances N-(9-fluorenyl)-N-methyl-beta-chloroethylamine (SKF 550), N-(3,4-dimethoxyphenylisopropyl)-N-benzyl-beta-chloroethylamin (SKF 625A) and N-(4-methoxyphenoxyisopropyl)-N-benzyl-beta-chloroethylamine (SKF 784A) were significantly more potent than phenoxybenzamine as Uptake(2) inhibitors, and were all less potent than phenoxybenzamine as Uptake(1) inhibitors. The compound SKF 550 is the most potent and selective inhibitor of Uptake(2) so far described. It has an IC50 for Uptake(2) of 0.08 muM, and an IC50 for Uptake(1) of approximately 40.0 muM.5. Comparison of the present results with the known activities of these blocking agents suggests that no correlation exists between adrenoceptor blocking activity and ability of the substances to act as inhibitors of Uptake(2) or Uptake(1).

Animals↗

Multiple remote-US preexposures and the blocking effect produced by a proximal-US.

Weanling, young-adult, and old-age Wistar albino rats were used to determine whether number of unconditioned stimulus (US) presentations, given 24 h or more (remote preexposure) prior to conditioning, alters the blocking effect of a single-US preexposure given 2 h before (proximal) taste aversion conditioning. As the number of remote-US preexposures increased from 0 to 6, the ability of the proximal-US preexposure to block conditioning initially increased then decreased for all age groups. Of the models put forth to explain US preexposure effects on conditioned taste aversion (CTA), only Wagner's information processing model adequately explained the reduction of the blocking effect of the proximal-US preexposure produced as a result of increasing remote-US preexposures.

Aging↗